Last reviewed · How we verify
POLESTAR Trial - An International Multi-center Early Discharge TAVI Program
An international multi-center prospective observational study to address safety and feasibility of an early discharge protocol in patients with symptomatic severe aortic stenosis who are eligible for transfemoral TAVI with the Boston Scientific ACURATE Neo Aortic Bioprosthesis transcatheter heart valve.
Details
| Lead sponsor | Erasmus Medical Center |
|---|---|
| Status | COMPLETED |
| Enrolment | 252 |
| Start date | Mon Apr 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Jan 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Aortic Valve Stenosis
Interventions
- Transcatheter Aortic Valve Implantation with ACURATE Neo Aortic Bioprosthesis
Countries
Belgium, Netherlands, Canada, United Kingdom